![Russell McMahen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Russell McMahen
Director Técnico/Científico/I+D en AYTU BIOPHARMA, INC. .
Cargos activos de Russell McMahen
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AYTU BIOPHARMA, INC. | Director Técnico/Científico/I+D | 01/01/2021 | - |
Historial de carrera de Russell McMahen
Antiguos cargos conocidos de Russell McMahen.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
NEOS THERAPEUTICS, INC. | Director de Operaciones | - | - |
Director Técnico/Científico/I+D | 30/07/2010 | 01/01/2021 | |
IVAX Pharmaceuticals, Inc.
![]() IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL. | Corporate Officer/Principal | - | - |
Formación de Russell McMahen.
Louisiana Tech University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Chief Operating Officer | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AYTU BIOPHARMA, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Neos Therapeutics, Inc.
![]() Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
IVAX Pharmaceuticals, Inc.
![]() IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL. | Health Technology |
- Bolsa de valores
- Insiders
- Russell McMahen
- Experiencia